ASEP Medical Holdings Inc.
ASEP
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -123.97% | 89.98% | -455.27% | 54.31% | -77.25% |
| Total Depreciation and Amortization | -2.05% | -41.54% | 6.97% | -1.42% | 2.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 149.33% | -108.50% | 1,513.44% | -131.30% | 433.16% |
| Change in Net Operating Assets | -95.49% | -39.06% | 421.14% | -152.95% | -49.71% |
| Cash from Operations | -468.52% | 53.85% | 73.32% | -185.69% | -192.11% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -120.82% | -- | -- |
| Cash from Investing | -- | -- | -120.82% | -- | -- |
| Total Debt Issued | 836.91% | 9,925.00% | -99.61% | -55.84% | 249.85% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 818.40% | 9,500.00% | -99.60% | -55.64% | 262.93% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -36.05% | 90.90% | -175.12% | 1,579.31% | 572.09% |